Advertisement

Aetiological factors in immune-mediated liver disease

  • A. L. W. F. Eddleston

Abstract

Immunological reactions have long been thought to be of importance in the pathogenesis of two main types of chronic liver disease, namely chronic active hepatitis and primary biliary cirrhosis. More recently, however, there has been an increasing awareness of the involvement of immune responses in the production of acute liver injury induced by viruses or drugs. This, in turn, has focused attention on the possible aetiological role of these agents in chronic liver disease. Although the hepatitis B virus appears to play no part in the development of primary biliary cirrhosis there is now considerable evidence to suggest that it may be a common aetiological agent in chronic active hepatitis. The discovery of the hepatitis B antigen greatly facilitated progress in this area. Using sensitive techniques for detecting both the viral product itself and immune responses to it, important links have been established between acute hepatitis and chronic active hepatitis and it is now possible to sketch the outlines of the complex cellular and humoral interactions which determine the clinical expression of hepatitis B virus infection.

Keywords

Chronic Liver Disease Primary Biliary Cirrhosis Acute Hepatitis Chronic Active Hepatitis Aetiological Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    World Health Organization Consultation on Viral Hepatitis (1970). Viral hepatitis and tests for the Australia (hepatitis-associated) antigen and antibody. Bull. Wld. Hlth. Org., 42, 957Google Scholar
  2. 2.
    Krugman, S., Giles, J. P. and Hammond, J. (1967). Infectious hepatitis— evidence for two distinctive clinical, epidemiological and immunological types of infection. J. Amer. Med. Ass., 200, 365CrossRefGoogle Scholar
  3. 3.
    Mosley, J. W. (1965). The surveillance of transfusion-associated viral hepatitis. J. Amer. Med. Ass., 193, 1007CrossRefGoogle Scholar
  4. 4.
    Blumberg, B. S. (1964). Polymorphisms of the serum proteins and the development of isoprecipitins in transfused patients. Bull. N. Y. Acad. Med., 40, 377PubMedGoogle Scholar
  5. 5.
    Blumberg, B. S., Gerstley, B. J. S., Hungerford, D. A., London, W. T. and Sutnick, A. I. (1967). A serum antigen (Australia antigen) in Down’s syndrome, leukemia and hepatitis. Ann. Intern. Med., 66, 924PubMedGoogle Scholar
  6. 6.
    World Health Organization (1973). Viral hepatitis. Report of a WHO Scientific Group. Tech. Rep. Ser. Wld. Hlth. Org. No. 512 Google Scholar
  7. 7.
    Almeida, J. D., Rubinstein, D. and Stott, E. J. (1971). New antigen-antibody system in Australia antigen-positive hepatitis. Lancet, ii, 1225CrossRefGoogle Scholar
  8. 8.
    Feinstone, S. M., Kapikian, A. Z. and Purcell, R. H. (1973). Hepatitis A: detection by immune electron microscopy of a virus-like antigen associated with acute illness. Science, 182, 1026PubMedCrossRefGoogle Scholar
  9. 9.
    Almeida, J. D., Gay, F. W. and Wreghitt, T. G. (1974). Pitfalls in the study of hepatitis A. Lancet, ii, 738Google Scholar
  10. 10.
    Dienstag, J. L., Feinstone, S. ZVL, Kapikian, A. Z. and Purcell, R. H. (1975). Immune electron microscopy and hepatitis A. Lancet, i, 102CrossRefGoogle Scholar
  11. 11.
    Del Prete, S., Costantino, D., Doglia, M., Graziina, A., Ajdukiewicz, A., Dudley, F. J., Fox, R. A. and Sherlock, S. (1970). Detection of a new serum antigen in three epidemics of short incubation hepatitis. Lancet, ii, 579CrossRefGoogle Scholar
  12. 12.
    Taylor, P. E., Almeida, J. D., Zuckerman, A. J. and Leach, J. M. (1972). Relationship of Milan antigen to abnormal serum lipoprotein. Amer. J. Dis. Child, 123, 329PubMedGoogle Scholar
  13. 13.
    Nielsen, J. O., Dietrichson, O., Elling, P. and Christoffersen, P. (1971). Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis. New Eng. J. Med., 285, 1157PubMedCrossRefGoogle Scholar
  14. 14.
    Gallagher, N. D. and Goulston, S. J. M. (1962). Persistent acute viral hepatitis. Brit. Med. J., i, 906CrossRefGoogle Scholar
  15. 15.
    Sidi, S., Michel, H. and Redeker, A. (1972). Unresolved (persistent) viral hepatitis. Abstract 7th Meet. EASL, Arnhem Google Scholar
  16. 16.
    Cooksley, W. G. E., Powell, L. W., Mistilis, S. P., Olsen, G., Mathews, J. D. and Mackay, I. R. (1972). Australia antigen in active chronic hepatitis in Australia: results in 130 patients from three centres. Austr. N.Z.J. Med., 2, 261CrossRefGoogle Scholar
  17. 17.
    Bianchi, P., Bianchi Porro, C., Coltorti, M., Dardanoni, L., Del Vecchio Blanco, C., Fagiolo, U., Farini, R., Menozzi, L., Naccarato, R., Pagliaro, R., Spano, C. and Verme, G. (1972). Occurrence of Australia antigen in chronic hepatitis in Italy. Gastroenterology, 63, 482PubMedGoogle Scholar
  18. 18.
    Gitnick, G. L., Gleich, G. J., Schoenfield, L. J., Baggenstoss, A. H., Sutnick, A. I., Blumberg, B. S., London, W. T. and Summerskill, W. H. J. (1969). Australia antigen in chronic active liver disease and cirrhosis. Lancet, ii, 285CrossRefGoogle Scholar
  19. 19.
    Wright, R., McCollum, R. W. and Klatskin, G. (1969). Australia antigen in acute and chronic liver disease. Lancet, ii, 117CrossRefGoogle Scholar
  20. 20.
    Sherlock, S., Fox, R. A., Niazi, S. P. and Scheuer, P. J. (1970). Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet, i, 1243CrossRefGoogle Scholar
  21. 21.
    Reed, W. D., Eddleston, A. L. W. F., Stern, R. B., Williams, R., Zuckerman, A. J., Bowes, A. and Earl, P. M. (1973). Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain. Lancet, ii, 690CrossRefGoogle Scholar
  22. 22.
    Bulkley, B. H., Goldfinger, S. E., Heizer, W. D., Isselbacher, K. J. and Shulman, N. R. (1970). Distinctions in chronic active hepatitis based on circulating hepatitis-associated antigen. Lancet, ii, 1323CrossRefGoogle Scholar
  23. 23.
    Lee, W. M., Reed, W. D., Mitchell, C. G., Galbraith, R. M., Eddleston, A. L. F. W., Zuckerman, A. J. and Williams, R. (1975). Cellular and humoral immunity to the heptitis-B surface antigen in active chronic hepatitis. Brit. Med. J., 1, 705PubMedCrossRefGoogle Scholar
  24. 24.
    Reinicke, V., Dybkjaer, E., Poulsen, H., Banke, O., Lylloff, K. and Nordenfeld, E. (1972). A study of Australia-antigen-positive blood donors and their recipients, with special reference to liver histology. New Eng. J. Med., 286, 867PubMedCrossRefGoogle Scholar
  25. 25.
    Woolf, L L., Boyes, B. E., Jones, D. M., Whittaker, J. S., Tapp, E., MacSween, R. N. M., Renton, P. H., Stratton, F. and Dymock, I. W. (1974). Asymptomatic liver disease in hepatitis-B antigen carriers. J. Clin. Path., 27, 348PubMedCrossRefGoogle Scholar
  26. 26.
    Hadziyannis, S., Vissoulis, C., Moussouros, A. and Afroudakis, A. (1972). Cytoplasmic localisation of Australia antigen in the liver. Lancet, i, 976CrossRefGoogle Scholar
  27. 27.
    Gerstley, B. J. S., Custer, R. P., Blumberg, B. S., London, W. T., Sutnick, A. I. and Coyne, V. Z. (1972). Liver biopsies in patients with and without Australia antigen. Arch. Path., 93, 366PubMedGoogle Scholar
  28. 28.
    Grange, M. J., Erlinger, S., Teillet, F., Schlegal, N., Barge, J. and Degott, C. (1973). A possible relationship to treatment between hepatitis-associated antigen and chronic persistent hepatitis in Hodgkin’s disease. Gut, 14, 433PubMedCrossRefGoogle Scholar
  29. 29.
    Le Bouvier, G. L. (1971). The heterogeneity of Australia antigen. J. Infect. Dis., 123, 671PubMedCrossRefGoogle Scholar
  30. 30.
    Holland, P. V., Purcell, R. H., Smith, H. and Alter, H. J. (1972). Subtyping of hepatitis-associated antigen (HB Ag); simplified technique with counter electrophoresis. J. Immunol., 109, 420PubMedGoogle Scholar
  31. 31.
    Iwarson, S., Magnius, L., Lindholm, A. and Lundin, P. (1973). Subtypes of hepatitis B antigen in blood donors and post-transfusion hepatitis: clinical and epidemiological aspects. Brit. Med. J., i, 84Google Scholar
  32. 32.
    Kim, C. Y. and Tilles, J. G. (1971). Immunologic and electrophoretic heterogeneity of hepatitis-associated antigen. J. Infect. Dis., 123, 618PubMedCrossRefGoogle Scholar
  33. 33.
    Van Kooten Kok-Doorschodt, H. J., Van den Akker, R. and Gispen, R. (1972). Determination and distribution of two types of hepatitis-associated antigen. J. Infect. Dis., 126, 117CrossRefGoogle Scholar
  34. 34.
    Magnius, L. O., Berg. R., Fjorvatn, B., Espmark, J. A. and Svedmyr, A. (1972). Evidence for a change in the dominant subtypes of HBAg associated with clinical hepatitis. (In preparation, 1972; cited in Iwarson etalP) Google Scholar
  35. 35.
    Magnius, L. O., and Espmark, J. A. (1972). New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. J. Immunol., 109, 1017Google Scholar
  36. 36.
    Nielsen, J. O., Dietrichson, O. and Juhl, E. (1974). Incidence and meaning of the ‘e’ determinant among hepatitis-B antigen positive patients with acute and chronic liver diseases. Lancet, ii, 913CrossRefGoogle Scholar
  37. 37.
    Magnius, L. O., (1975). Characterisation of a new antigen-antibody system associated with hepatitis B. Clin. Exp. Immunol., 20, 209PubMedGoogle Scholar
  38. 38.
    Hotchin, J. (1971). Virus, cell surface, and self: Lymphocytic choriomeningitis of mice. Am. J. Clin. Path., 56, 333PubMedGoogle Scholar
  39. 39.
    Nielsen, J. O., Remecke, V., Dietrichson, O., Andersen, V., Thomsen, M. and Andersen, E. (1973). Immunological studies of Australia antigen carriers with and without liver diseases. Clin. Exp. Immunol., 15, 9Google Scholar
  40. 40.
    Yeung Laiwah, A. A. C. (1971). Lymphocyte transformation by Australia antigen. Lancet, ii, 470CrossRefGoogle Scholar
  41. 41.
    Dudley, F. J., Giustino, V. and Sherlock, S. (1972). Cell-mediated immunity in patients positive for hepatitis-associated antigen. Brit. Med. J., iv 754CrossRefGoogle Scholar
  42. 42.
    Lee, W. M., Reed, W. D., Mitchell, C. G., Woolf, I. L., Dymock, I. W., Eddleston, A. L. W. F., and Williams, R. (1975). Cell-mediated immunity to hepatitis B surface antigen in blood donors with persistent anti-genaemia. Gut, 16, 416PubMedCrossRefGoogle Scholar
  43. 43.
    Walsh, J. H., Yalow, R. S. and Berson, S. A. (1970). Radioimmunoassay of Australia antigen. Vox Sang., 19, 217PubMedCrossRefGoogle Scholar
  44. 44.
    Reed, W. D., Mitchell, C. G., Eddleston, A. L. W. F., Lee, W. M., Williams, R. and Zuckerman, A. J. (1974). Exposure and immunity to hepatitis-B virus in a liver unit. Lancet, i, 581CrossRefGoogle Scholar
  45. 45.
    Mitchell, C. G., Smith, M. G. M., Golding, P. L., Eddleston, A. L. W. F. and Williams, R. (1972). Evaluation of the leucocyte migration test as a measure of delayed hypersensitivity in man. Clin. Exp. Immunol., 11, 535PubMedGoogle Scholar
  46. 46.
    Kempe, C. H. (i960). Studies on smallpox and complications of smallpox vaccination. Pediatrics, 26, 176Google Scholar
  47. 47.
    Galbraith, R. M., Smith, M., Mackenzie, R. M., Tee, D. E., Doniach, D. and Williams, R. (1974). High prevalance of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis. New Eng. J. Med., 290, 63PubMedCrossRefGoogle Scholar
  48. 48.
    Dawkins, R. L. and Joske, R. A. (1973). Immunoglobulin deposition in liver of patients with active chronic hepatitis and antibody against smooth muscle. Brit. Med. J., 2, 643PubMedCrossRefGoogle Scholar
  49. 49.
    Smith, M. G. M. Golding, P. L., Eddleston, A. L. W. F., Mitchell, C. G., Kemp, A. and Williams, R. (1972). Cell-mediated immune responses in chronic liver diseases. Brit. Med. J., i, 527CrossRefGoogle Scholar
  50. 50.
    Hopf, U., Meyer zum Buschenfelde, K. H. and Freudenberg, J. (1974). Liver-specific antigen of different species. Clin. Exp. Immunol., 16, 117Google Scholar
  51. 51.
    Meyer zum Buschenfelde, K. H., Kossling, F. K. and Miescher, P. A. (1972). Experimental chronic active hepatitis in rabbits following immunization with human liver proteins. Clin. Exp. Immunol., 11, 99Google Scholar
  52. 52.
    Hopf, U. and Meyer zum Buschenfelde, K. H. (1974). Studies on the pathogenesis of the experimental active chronic hepatitis (ACH) in rabbits. Digestion, 10, 306Google Scholar
  53. 53.
    Thomson, A. D., Cochrane, M. A. G., McFarlane, I. G., Eddleston, A. L. W. F. and Williams, R. (1974). Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis. Nature (JLond.), 252, 721CrossRefGoogle Scholar
  54. 54.
    Eddleston, A. L. W. F., and Williams, R. (1974). Inadequate antibody response to HBAg or suppressor T-cell defect in development of active chronic hepatitis. Lancet, ii, 1543CrossRefGoogle Scholar
  55. 55.
    Allison, A. C., Denman, A. M. and Barnes, R. D. (1971). Co-operating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet, ii, 135CrossRefGoogle Scholar
  56. 56.
    MacLennan, L C M., Loewi, G. and Howard, A. (1969). A human serum immunoglobulin with specificity for certain homologous target cells, which induces target cell damage by normal human lymphocytes. Immunology, 17, 897PubMedGoogle Scholar
  57. 57.
    McDevitt, H. O. and Bodmer, W. F. (1974). HL-A, immune-response genes, and disease. Lancet, i, 1269CrossRefGoogle Scholar
  58. 58.
    Stiffel, C., Mouton, D., Bouthillier, Y., Henmann, A. M., Decreusefond, C., Mevel, J. C. and Biozzi, G. (1974). Polygenic regulation of general antibody synthesis in the mouse. In Progress in Immunology, II, Vol 2. L. Brent and E. J. Holborow (eds). p. 203. (Amsterdam: North Holland)Google Scholar
  59. 59.
    Galbraith, R. M., Eddleston, A. L. W. F., Smith, M. G. M., Williams, R., MacSween, R. N. M., Watkinson, G., Dick, Heather, Kennedy, L. A. and Batchelor, J. R. (1974). Histocompatibility antigens in active chronic hepatitis and primary biliary cirrhosis. Brit. Med. J., 3, 604PubMedCrossRefGoogle Scholar
  60. 60.
    Triger, D. R., Kurtz, J. B., MacCallum, F. O., Wright, R. (1972). Raised antibody titres to measles and rubella viruses in chronic active hepatitis. Lancet, i, 665CrossRefGoogle Scholar
  61. 61.
    Da Costa, J. A. G., White, A. G., Parker, A. C. and Grigor, G. B. (1974). Increased incidence of HL-A 1 and 8 in patients showing IgG or complement coating on their red cells. J. Clin. Path., 27, 353PubMedCrossRefGoogle Scholar
  62. 62.
    Tsantoulas, D. C., McFarlane, I. G., Portmann, B., Eddleston, A. L. W. F. and Williams, R. (1974). Cell-mediated immunity to human Tamm-Horsfall glycoprotein in autoimmune liver disease with renal tubular acidosis. Brit. Med. J., 4, 491PubMedCrossRefGoogle Scholar
  63. 63.
    Davis, M. and Williams, R. (1976). Drugs and the liver. In Textbook of adverse drug reactions, D. M. Davies (ed.). In pressGoogle Scholar
  64. 64.
    Reynolds, T. B., Peters, R. L. and Yamada, S. (1971). Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. New Eng. J. Med., 285, 813PubMedCrossRefGoogle Scholar
  65. 65.
    Elkington, S. G., Schreiber, W. M. and Conn, H. O. (1969). Hepatic injury caused by L-alpha-methyldopa. Circulation, 40, 589PubMedGoogle Scholar
  66. 66.
    Goldstein, G. B., Lam, K. C. and Mistilis, S. P. (1973)-Drug-induced active chronic hepatitis. Am. J. Dig. Dis., 18, 177PubMedCrossRefGoogle Scholar
  67. 67.
    Schweitzer, I. L. and Peters, R. L. (1974). Acute submassive hepatic necrosis due to methyldopa. A case demonstrating possible initiation of of chronic liver disease. Gastroenterology, 66, 1203PubMedGoogle Scholar
  68. 68.
    Shikata, T., Uzawa, T., Yoshiwara, N., Akatsuka, T. and Yamazaki, S. (1974). Staining methods of Australia antigen in paraffin section-detection of cytoplasmic inclusion bodies. Jap. J. Exp. Med., 44, 25PubMedGoogle Scholar
  69. 69.
    Krohn, K., Finlayson, N. D. C., Jokelainen, P. T., Anderson, K. E. and Prince, A. M. (1970). Electron microscopical and immunological observations on the serum-hepatitis (SH) antigen in primary biliary cirrhosis. Lancet, ii, 379CrossRefGoogle Scholar
  70. 70.
    Maddrey, W. C., Saito, S., Shulman, N. R. and Klatskin, G. (1972). Coincidental Australia antigenaemia in primary biliary cirrhosis. Ann. Intern. Med., 76, 705PubMedGoogle Scholar
  71. 71.
    Tsantoulas, D. C., McFarlane, I. G., Portmann, B., Eddleston, A. L. W. F. and Williams, R. (1974). Sensitisation to human bile proteins in primary biliary cirrhosis and active chronic hepatitis: demonstration of antigenic material in bile duct epithelial cells. Digestion, 10, 305.Google Scholar

Copyright information

© MTP Press Ltd. 1976

Authors and Affiliations

  • A. L. W. F. Eddleston

There are no affiliations available

Personalised recommendations